We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.37B
AUM Growth
+$19.3M
Cap. Flow
-$140M
Cap. Flow %
-2.6%
Top 10 Hldgs %
34.27%
Holding
97
New
8
Increased
22
Reduced
54
Closed
3

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$16.3M
2
TFC icon
Truist Financial
TFC
+$12.2M
3
EMN icon
Eastman Chemical
EMN
+$10.3M
4
SPR
Spirit AeroSystems
SPR
+$9.6M
5
IIF
Morgan Stanley India Investment Fund
IIF
+$4.36M

Top Sells

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$57.5M
2
ORCL icon
Oracle
ORCL
+$26.5M
3
GEHC icon
GE HealthCare
GEHC
+$15.5M
4
QSR icon
Restaurant Brands International
QSR
+$11.4M
5
SKX
Skechers
SKX
+$8.34M

Sector Composition

Rank Sector Weight
1 Financials 29.93%
2 Communication Services 17.12%
3 Materials 11.29%
4 Energy 10.11%
5 Technology 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VT icon
76
Vanguard Total World Stock ETF
VT
$81B
$946K 0.02%
9,750
– –
URTH icon
77
iShares MSCI World ETF
URTH
$8.19B
$921K 0.02%
+7,400
New +$888K
ING icon
78
ING
ING
$105B
$911K 0.02%
67,597
-2,113
-3% -$27K
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$762K 0.01%
+1,720
New +$722K
MET icon
80
MetLife
MET
$62.1B
$732K 0.01%
12,949
– –
VTWO icon
81
Vanguard Russell 2000 ETF
VTWO
$16.9B
$529K 0.01%
+7,000
New +$504K
GOOGL icon
82
Alphabet (Google) Class A
GOOGL
$4.27T
$302K 0.01%
2,520
+300
+14% +$34.5K
OM icon
83
Outset Medical
OM
$59.2M
$296K 0.01%
903
+146
+19% +$44.5K
ENB icon
84
Enbridge
ENB
$105B
$285K 0.01%
7,650
– –
KMB icon
85
Kimberly-Clark
KMB
$33B
$280K 0.01%
2,025
– –
DUK icon
86
Duke Energy
DUK
$92.8B
$278K 0.01%
3,100
– –
MSFT icon
87
Microsoft
MSFT
$3.75T
$221K ﹤0.01%
+648
New +$203K
MLYS icon
88
Mineralys Therapeutics
MLYS
$2.56B
$194K ﹤0.01%
+11,400
New +$170K
PROK icon
89
ProKidney
PROK
$378M
$178K ﹤0.01%
+15,900
New +$169K
CVE.WS
90
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$170K ﹤0.01%
15,257
+3
+0% +$36
LYRA
91
DELISTED
LYRA THERAPEUTICS INC
LYRA
$131K ﹤0.01%
+638
New +$88.6K
CBIO
92
Crescent Biopharma
CBIO
$731M
$78.7K ﹤0.01%
453
– –
MDNA
93
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$57.8K ﹤0.01%
120,000
-50,000
-29% -$30.9K
ATRA icon
94
Atara Biotherapeutics
ATRA
$92.8M
$28.2K ﹤0.01%
700
– –
ADNT icon
95
Adient
ADNT
$1.45B
– –
-1,403,273
Closed -$57.5M
GEHC icon
96
GE HealthCare
GEHC
$29B
– –
-188,971
Closed -$15.5M
BLU
97
DELISTED
BELLUS Health Inc.
BLU
– –
-21,500
Closed -$155K
1 2 3
4

Similar funds

JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Letko, Brosseau & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Letko, Brosseau & Associates held 97 positions worth $5.37B, up 0.36% from $5.35B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Letko, Brosseau & Associates's Q2 2023 filing shows 8 new, 22 increased, 54 reduced and 3 closed positions. Its largest new stake was Morgan Stanley India Investment Fund: 215,000 shares worth $4.66M. The largest sale was Adient, an estimated $57.5M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q2 2023 buy was Morgan Stanley India Investment Fund: 215,000 shares worth $4.66M.
  • Letko, Brosseau & Associates added most to Pfizer in Q2 2023, an estimated $16.3M increase.
  • Letko, Brosseau & Associates's biggest Q2 2023 reduction was Oracle, cutting an estimated $26.5M.
  • Letko, Brosseau & Associates fully exited Adient in Q2 2023, selling an estimated $57.5M.
  • Letko, Brosseau & Associates's ten largest holdings make up 34% of its $5.37B portfolio in Q2 2023.
  • Letko, Brosseau & Associates opened 8 new positions and closed 3 in Q2 2023.
  • Letko, Brosseau & Associates's portfolio value rose 0.36% quarter-over-quarter to $5.37B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2023, filed 10 Aug 2023.